Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2018 Sep 25;6:92. doi: 10.1186/s40425-018-0410-2

Correction to: CART cells are prone to Fas- and DR5-mediated cell death

Benjamin O Tschumi 1, Nina Dumauthioz 1, Bastien Marti 1, Lianjun Zhang 1, Evripidis Lanitis 2,3, Melita Irving 2,3, Pascal Schneider 4, Jean-Pierre Mach 4, George Coukos 2,3, Pedro Romero 1, Alena Donda 1,
PMCID: PMC6154881  PMID: 30253808

Correction

After publication of this article [1], it was noticed that 3 authors were missed from the author list. These authors are Evripidis Lanitis, Melita Irving and George Coukos. The correct author list can be seen above and updated Competing Interests, Authors’ Contributions and Acknowledgements can be seen below.

Acknowledgements

We are grateful to P. Reichenbach for sharing his expertise in DNA cloning strategies. Special thanks to Prof. M. Thome for sharing her expertise in the field of T cell signalling.

Authors’ contributions

AD and BT designed and developed the study. BT, ND, BM and LZ performed the experiments, acquired and analyzed the data. E.L. has set up the protocol of transduction of murine primary lymphocytes. EL, MI and GC contributed to the conception, experimental design and analysis of results. PS shared his expertise on programmed cell death and provided essential reagents. AD, BT, LZ, PR and JPM wrote the manuscript. All authors read and approved the final manuscript.

Competing interests

All co-authors declare that they have no competing interests.

Reference

  • 1.Tschumi BO, Dumauthioz N, Marti B, Zhang L, Schneider P, Mach J-P, et al. CART cells are prone to Fas- and DR5-mediated cell death. J Immuno Cancer. 2018;6:71. doi: 10.1186/s40425-018-0385-z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES